Research Insight
Research Insight
BostonGene Announces Cancer Research Collaboration with the Abramson Cancer Center of the University of Pennsylvania
BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, announced a Master Clinical Research Collaboration Agreement with the Abramson Cancer Center (ACC) of the University of Pennsylvania to support multiple research projects...
Research Insight
Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Evidence Related to COVID-19 and Cancer
Syapse®, a real-world data company accelerating the delivery of precision medicine through the Syapse Learning Health NetworkTM, and the U.S. FDA Oncology Center of Excellence (OCE) have expanded an existing multi-year Research Collaboration Agreement (RCA) focused on the use...
Research Insight
Majority of Americans taking Blood Thinners indicate the fear of major bleeding.
A majority (55 percent) of Americans aged 18 and older currently prescribed anticoagulant medications (blood thinners) report that they very much or somewhat fear experiencing a life-threatening bleed and 73 percent say that they are more cautious about routine...
Research Insight
Digital platform to reduce the risk of infections during surgery
One in ten people in hospital care develops a healthcare-related infection. Together with Getinge, Semcon is developing a new digital platform to make it easier to identify where the risk of infections during surgery is greatest. Â
In Sweden, infections are...
Research Insight
Improving the lives of patients suffering from chronic pain
For patients suffering from chronic pain, their lives can be miserable if the pain relief on which they rely is inefficient. It is essential, therefore, to support them in improving their situation to continue to live fulfilling and happy...
Research Insight
University of Glasgow leads COVID-19 research response in Scotland
The University of Glasgow is at the heart of COVID-19 research response in Scotland and the UK. Covid-19 is a new disease in humans, caused by a member of the coronavirus family of viruses. Thought to have originated in...
Research Insight
St. Elizabeth Healthcare Partners with CTI and Pulmotect Becoming First Hospital Site for Phase-2 Clinical Trial Targeting COVID-19
St. Elizabeth Healthcare has been selected as the first site of the FDA-approved Phase-2 COVID-19 clinical trial studying the drug PUL-042 of Pulmotect, Inc., in partnership with CTI - Clinical Trial and Consulting Services (CTI), a global full-service contract...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
